UI study: No 'uncomplicated joy' in good news for individuals tested for Huntington disease

October 29, 2000

IOWA CITY, Iowa -- Good news from genetic screening tests can bring more to its recipients than relief: it also can bring doubts about the future and, in some cases, guilt. A University of Iowa study reported recently that individuals who received negative results from genetic screening for Huntington disease -- meaning they did not carry the gene mutation that causes the debilitating and fatal disorder -- usually "were not prepared for the implications of a 'good news' test outcome."

"They never reported uncomplicated joy," said Janet Williams, Ph.D., associate professor of nursing at the UI and principal investigator for the study. "The joy and relief were accompanied by concerns" about how family members might receive the news and how to adjust to a life now free of anxiety about when symptoms of Huntington disease might begin to appear. Some even doubted the test results, the study reported.

Published in the journal Research in Nursing & Health, the study involved a small number of individuals over a relatively short period of time. Even so, Williams said, it identified important themes with respect to genetic testing. First and foremost, informed consent and one-on-one counseling should be a part of every testing program.

"Many of the people we talked with were working this out on their own," Williams said. "Health providers should be aware that this is a group that may benefit from supportive counseling."

Huntington disease affects about one in 20,000 people and is caused by a single gene mutation. Individuals who carry the mutation almost invariably develop the disease unless they die of some other cause prior to its onset. Huntington disease is characterized by a progressive loss of cognitive and physical function and usually begins to manifest itself between the ages of 30 and 50. The course of the disease may last anywhere from 10 to 25 years.

Each child of an individual with Huntington disease has a 50 percent chance of inheriting the gene mutation. Thus, Williams said, families with a history of Huntington disease generally have an intimate understanding of the illness and a sense of shared risk. When a family learns one of its members has sought genetic testing for the mutation, its group dynamic may be altered irreversibly. "People who have this test are often departing from family norms," Williams said, "and that somewhat isolates these individuals."

Family relationships may be further upset when an individual's negative test result contradicts the expectation that he or she will develop the disease. Williams explained that a phenomenon known as preselection often exists within families with a history of Huntington disease. Consciously or unconsciously, family members assign risk to individuals based on beliefs about who is likely to develop the illness; for example, if in previous generations the oldest child often inherited Huntington disease, family members may assume that will be true in their case as well.

When that assumption proves false, Williams said, families face the need to adapt. "Biological information such as this removes the comfort they may have had in 'knowing' who was going to get the disease," she said. "There are a number of issues that mean life is not going to be the same within the family once a person learns they don't have it."

The individual's response to a negative test result is no less complicated. According to the study, "Adults with normal results had prepared themselves for the worst, and they expected that they would have the gene mutation."

"I think that's their coping mechanism," said Catherine Evers, a co-author of the study and an advanced practice nurse who is coordinator of the Regional Genetic Consultation Service based at UI Hospitals and Clinics. "When you tell them they don't have it, based on a gene test that's very accurate, some of them have a hard time believing you," Evers said. "We've had individuals say to us, 'we'd better do the test again.'"

Study participants had difficulty knowing how to relate to family members who might have the disease. One individual spoke of encountering a cousin who has Huntington disease, "who I related to really easily before, because I figured I was going to be in the same boat, but it was harder for me to feel the same empathy.... I didn't tell him, I could not tell him my test results." Another reported that while some relatives were supportive, "there's been other people that have been almost jealous. That's the ones that I regret telling."

Ultimately, the study said, individuals who learn they do not carry the gene for Huntington disease face the need to redefine their goals and purpose in life. Six months after learning their test results, participants "began to discard their prior assumptions and started to consider themselves as healthy individuals who might live a long life."

"It gives them a whole different perspective on what their potential is," Evers said. "We do see people who change jobs, or go to school who hadn't gone to school."
-end-
Contact: Derek Maurer
Health Science Relations
(319) 335-8964
(319) 351-0227 Home
derek-maurer@uiowa.edu

University of Iowa

Related Genetic Testing Articles from Brightsurf:

Genetic testing cost effective for newly diagnosed GIST
UC San Diego School of Medicine researchers reported that genetic testing is cost-effective and beneficial for newly diagnosed patients with metastatic gastrointestinal stromal tumors (GIST), a rare type of cancer.

Genetic testing could improve screening for osteoporosis
An international team of scientists has developed a novel genetic measure that could dramatically improve how doctors assess the risk of sustaining a fracture due to osteoporosis or fragility

New recommendations on genetic testing for prostate cancer
Genetic testing for prostate cancer is still not common. New guidelines show why it's important, and which genes to test for.

For acute myeloid leukemia, genetic testing is often worth the wait
New tailored therapies offer exciting prospects for treating acute myeloid leukemia (AML), but taking advantage of them may require waiting a week or more for genetic testing before starting treatment, posing a dilemma for doctors and patients facing this deadly and often fast-moving disease.

Genetic testing among individuals with ASD
Professional medical societies recommend certain genetic tests for individuals with autism spectrum disorder (ASD).

Breast cancer patients to be evaluated for genetic testing
The guidance from the ACMG differs from a consensus guideline issued in February by the American Society of Breast Surgeons, which recommended genetic testing for all newly diagnosed patients with breast cancer.

New technique isolates placental cells for non-invasive genetic testing
A new technique for isolating cells carrying the full fetal genome from cervical swabs could enable doctors to diagnose genetic disorders without using needles to harvest cells from the placenta.

BRCA1/2 genetic testing recommendations still leave issues unresolved
The U.S. Preventive Services Task Force offers new guidelines on BRCA1/2 genetic testing.

Does genetic testing pose psychosocial risks?
For the last quarter century, researchers have been asking whether genetic information might have negative psychosocial effects.

Genetic testing has a data problem; New software can help
As at-home genetic testing becomes more popular, companies are grappling with how to store all the accumulating data and how to process results quickly.

Read More: Genetic Testing News and Genetic Testing Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.